P4 medicine approach to obstructive sleep apnoea. Issue 5 (5th May 2017)

• Record Type: Journal Article
• Authors: Lim, Diane C.; Sutherland, Kate; Cistulli, Peter A.; Pack, Allan I.
• Is Part Of: Respirology. Volume 22:Issue 5(2017)
• Page Start: 849
• Page End: 860
• Publication Date: 2017-05-05
• Subjects: continuous positive airway pressure -- intraoral devices -- obesity -- obstructive sleep apnoea -- precision medicine; Respiratory organs -- Diseases -- Periodicals; Respiratory organs -- Periodicals; 612.2
• DOI: 10.1111/resp.13063
• Languages: English
• ISSNs: 1323-7799

Abstract

ABSTRACT: P4 medicine is an evolving approach to personalized medicine. The four Ps offer a means to: Predict who will develop disease and co‐morbidities; Prevent rather than react to disease; Personalize diagnosis and treatment; have patients Participate in their own care. P4 medicine is very applicable to obstructive sleep apnoea (OSA) because each OSA patient has a different pathway to disease and its consequences. OSA has both structural and physiological mechanisms with different clinical subgroups, different molecular profiles and different consequences. This may explain why there are different responses to alternative therapies, such as intraoral devices and hypoglossal nerve stimulation therapy. Currently, technology facilitates patients to participate in their own care from screening for OSA (snoring and apnoea apps) to monitoring response to therapy (sleep monitoring, blood pressure, oxygen saturation and heart rate) as well as monitoring their own continuous positive airway pressure (CPAP) compliance. We present a conceptual framework that provides the basis for a new, P4 medicine approach to OSA and should be considered more in depth: predict and prevent those at high risk for OSA and consequences, personalize the diagnosis and treatment of OSA and build in patient participation to manage OSA.